IDEX awards 16,595 restricted stock shares to CFO Gillen

IDEX Corporation reported an equity grant to its senior vice president and chief financial officer, Sean M. Gillen.

Rhea-AI Filing Summary

IDEX Corporation reported an equity grant to its senior vice president and chief financial officer, Sean M. Gillen. On 01/05/2026, he received 16,595 shares of common stock at a price of $0 per share as an equity award. These are restricted shares that vest in three substantially equal annual installments on each of the first, second and third anniversaries of the grant date, conditioned on his continued employment through each vesting date. Following this award, Gillen beneficially owns 16,595 shares of IDEX common stock in direct form.

Insider Trade Summary

Grant/Award: 16,595 shares

Grant/Award 1 txn

Insider Gillen Sean M.

Role SVP, Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	COMMON STOCK	16,595	$0.00	$0.00

Holdings After Transaction: COMMON STOCK — 16,595 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted shares, which vest in three substantially equal annual installments on each of the first, second and third anniversary of the grant date, subject to the Reporting Person's continuous employment through each such date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IDEX (IEX) disclose for Sean M. Gillen?

IDEX disclosed that its SVP and chief financial officer, Sean M. Gillen, received an award of 16,595 shares of IDEX common stock on 01/05/2026.

What type of shares were granted to the IDEX CFO in this Form 4?

The transaction represents an award of restricted shares of common stock, which are subject to vesting conditions rather than being fully unrestricted at grant.

How do the 16,595 restricted IDEX (IEX) shares vest for the CFO?

The 16,595 restricted shares vest in three substantially equal annual installments on each of the first, second and third anniversaries of the grant date, contingent on Mr. Gillen’s continuous employment through each vesting date.

Did the IDEX CFO pay anything for the 16,595 restricted shares?

No cash price was paid for the award. The filing shows a transaction price of $0 per share for the 16,595 restricted shares, reflecting a compensation grant.

How many IDEX shares does Sean M. Gillen own after this transaction?

After the reported grant, Sean M. Gillen beneficially owns 16,595 shares of IDEX common stock, held with direct ownership.

Is this IDEX (IEX) insider transaction a purchase or a compensation grant?

This transaction is a compensation grant of restricted common stock to the CFO at $0 per share, rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/07/2026 - 06:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gillen Sean M.

(Last) (First) (Middle)

3100 SANDERS ROAD

SUITE 301

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IDEX CORP /DE/ [ IEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	01/05/2026		A		16,595(1)	A	$0	16,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted shares, which vest in three substantially equal annual installments on each of the first, second and third anniversary of the grant date, subject to the Reporting Person's continuous employment through each such date.

	/s/ Sam Rayburn, by Power of Attorney	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.